神经节苷脂（GM1）合用依达拉奉治疗急性脑梗死28例临床观察  

作　　者：刘春华 褚剑英 

机构地区：[1]辉南县结核病防治所,吉林辉南135100 [2]辉南县辉南镇卫生院,吉林辉南135102

出　　处：《中国中医药咨讯》2011年第12期153-154,共2页

摘　　要：目的观察单唾液酸四己糖神经节苷脂钠注射液和依达拉奉注射液治疗急性脑梗死的疗效。方法将56例急性脑梗死患者，随机分为治疗组和对照组。对照组采用依达拉奉注射液，治疗组在对照组基础上加用神经节苷脂钠注射液，一个疗程后（10天）观察急性脑梗死的改善情况。结果治疗组临床总有效率为92．8％，对照组为78．6％，治疗组疗效明显优于对照组（P〈0．01）。结论神经节苷脂（GM1）合用依达拉奉能提高急性脑梗死病人的临床治疗效果。Purpose To observe the curative effect of monosialotetrahexosylganglioside, GM 1 injection combines with Edaravone injection therapy the acute stroke. Methods 56 cases of the acute stroke were randomly divided into a treatment group and a control group, 28 cases in each group. The treatment group were treated with GM1 injection combines with Edaravone injection, the control group were treated with Edaravone injection. To observe the curative effect of after a period of treatment（ten day）. Results The total effective rate was 92.8% in the treatment group and 78.6% in the control group, the treatment group being better than the group （P〈0.01）. Conclusion Its effect on therapy the acute stroke was better in the therapy group than in the control group.

关 键 词：单唾液酸四己糖神经节苷脂钠 依达拉奉 急性脑梗死 

分 类 号：R722.12[医药卫生—儿科]